Christopher Chai

Christopher Chai is a seasoned finance professional with extensive experience in the biotech and investment sectors. Currently serving as a Venture Partner at SR One Capital Management since January 2021 and as a Board Member at Surrozen since April 2021, Christopher has a history of leadership roles, including Chief Financial Officer at Principia Biopharma and MAP Pharmaceuticals. Prior experience includes serving as Vice President of Treasury and Investor Relations at CV Therapeutics and various roles at J.P. Morgan, including Investment Banking Associate and Audit Officer. Christopher's board experience encompasses positions at TranscripTx and PATHWAYS HOSPICE FOUNDATION INC. Educationally, Christopher Chai holds a Bachelor of Science degree in Operations Research and Industrial Engineering from Cornell University.